金邦達寶嘉(03315.HK)中期純利減少6%至8200萬元 中期息3港仙
格隆匯8月17日丨金邦達寶嘉(03315.HK)公佈,截至2020年6月30日止6個月,公司收入5.525億元人民幣,同比減少15.4%;實現淨利潤約人民幣8200萬元,同比下降約6.0%;每股盈利9.9分,中期股息每股普通股港幣3.0仙。
期間集團加速數字化轉型,平台及服務板塊業務依然保持快速增長,實現收入約人民幣2.25億元,同比上升約23.8%,其佔總收入的比例由2019年度同期的約27.8%,上升到至約40.7%。
期間集團銷售毛利率和淨利潤率均獲得同比增長,分別增長約0.3個百分點至約28.8%和約1.4個百分點至約14.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.